Format

Send to

Choose Destination
See comment in PubMed Commons below
Semin Cell Dev Biol. 2001 Jun;12(3):215-23.

Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria.

Author information

  • 1Department of Molecular and Cell Biology, University of California, 229 Stanley Hall, Berkeley, CA 94720-3206, USA. nhiroshi@uclink4.berkeley.edu

Abstract

Bacteria, being unicellular, are constantly exposed to toxic compounds in their environment. Gram-negative bacteria and mycobacteria are unusually successful in surviving in the presence of toxic compounds because they combine two mechanisms of resistance. They produce effective permeability barriers, comprising the outer membrane and the mycolate-containing cell wall, on the cell surface. Further, they actively pump out drug molecules that trickle through the barrier, often utilizing multidrug efflux pumps. In Gram-negative bacteria, multidrug pumps of exceptionally wide specificity frequently interact with outer membrane channels and accessory proteins, forming multisubunit complexes that extrude drug molecules directly into the medium, bypassing the outer membrane barrier.

Copyright 2001 Academic Press.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk